Barclays maintains Beyond Meat at Underweight, lowers price target to $5 from $10

Barclays downgraded Beyond Meat to Underweight and cut its price target from $10 to $5, a 50% reduction. This implies a 30.1% downside from the Nov 4 close of $7.15.

Original reporting
Published Nov 5, 2026, 6:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 6:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barclays maintains Beyond Meat at Underweight, lowers price target to $5 from $10 — source image
Decision brief

The 30-second read

$BYNDBearishMed
01

Why it matters

The downgrade could trigger short‑term selling and may influence peer valuations.

02

Market read

Analyst target cut is a fresh catalyst that may drive BYND lower in the near term.

03

What to watch

Potential upcoming product launches or cost‑reduction initiatives not reflected in the target.

Relevance 6/10Novelty 6/10Timing: pre‑market today

Background

Barclays' target revision follows recent volatility in the plant‑based sector and broader market pressure on growth stocks.

Company-level read

Ticker impact

$BYNDBearishHigh confidence
Context

Barclays lowered Beyond Meat's price target to $5 from $10, indicating a fresh analyst downgrade.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

The 50% target cut signals reduced valuation expectations, prompting short‑term sell interest.

Market effects

May weigh on other plant‑based protein stocks as analysts reassess valuation multiples.

Limited to U.S. equity markets where BYND trades.

Low global impact; primarily affects U.S. investors.

Counterpoint

Some investors may view the cut as an overreaction and see buying opportunity at lower levels.

Key entities

  • Barclays

    Equity research firm issuing the target cut.

  • Beyond Meat

    U.S.-listed producer of plant‑based meat alternatives.

Related articles

$BYNDMed

Beyond Meat (BYND) Q3 2026 Earnings Call Transcript

Beyond Meat (BYND) reported Q3 2026 net revenues of $64.5M, down 8% YoY but stable sequentially. Gross margin improved to 19.3%, the highest in five years. The company is focusing on stabilizing its U.S. business, growing internationally, and driving operational efficiency. New products like Beyond Steak Filet and Ground Faba are showing early success.

$BYNDMed

Beyond Meat Inc (BYND) Q3 2026 Earnings Call Highlights: Margin Milestone Masks Revenue

Beyond Meat (BYND) reported Q3 2026 revenue of $64.5M, down 8.1% YoY, with declines across U.S. retail, foodservice, and international foodservice. Operating expenses were $105.4M, leading to a net loss of $82.8M. Gross margin improved to 19.3%, the highest in five years. Q4 revenue guidance is $54M-$59M. Management focuses on cost reduction and new product launches to stabilize the business.

$BYNDHighAI 8/10

What Beyond Meat (BYND) Said on Its Q3 Earnings Call

Beyond Meat reported Q3 sales volume down 10.9% but net revenue per pound up 3.2%. U.S. retail revenue fell 13.2% to $24.8M, while international retail revenue rose 13.3% to $17.9M. The company posted a net loss of $82.8M, narrower than last year's $97M loss. Adjusted EBITDA loss was $24.6M, improved from $33.5M a year earlier. Beyond Meat is focusing on stabilizing U.S. business and expanding into new products and markets.